DxN VERIS Molecular Diagnostics System Revolutionises Lab Workflow
Beckman Coulter Diagnostics is showcasing its revolutionary DxN VERIS Molecular Diagnostics System* at Innovations to Improve Workflow for the Diagnostics Laboratory, booth D23 and D24 at the IFCC-EFLM EuroMedLab, 22-24 June 2015, Palais des Congrès, Paris, France.
“The DxN VERIS Molecular Diagnostics System is designed to revolutionise the clinical laboratory with LEAN workflow and improved sample turn-around time,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “The system’s true single sample random access empowers laboratories to perform viral load tests whenever they want, at a time that suits them—ultimately helping physicians make faster clinical decisions and positively impacting the patient pathway.
“The robust DxN VERIS can run up to 20 assays at any time,” Kaldowski continues. “This enables laboratories to optimise workflows and staffing productivity, freeing up time, for example, to bring additional and new testing in-house, for laboratory service expansion and to increase reference site revenue potential.”
With LEAN principles at its core, DxN VERIS combines sample prep, nucleic acid extraction, reaction setup, real-time PCR amplification, detection and results interpretation in one instrument, streamlining workflow for improved productivity. “With DxN VERIS we have significantly reduced the need for manual intervention, enabling labs to go from a sample to auto-verified result in just 70 minutes,” said Richard Creager, senior vice president, Molecular Diagnostics Business Unit and chief scientific officer at Beckman Coulter Diagnostics.
Fully CE-marked, the system is available with assays for Human Immunodeficiency Virus (HIV-1), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and Human Cytomegalovirus (CMV). Further menu expansion will follow with many other assays currently in development.
DxN VERIS assays are supplied in a unique, single cartridge system so, unlike traditional batch-plate systems, there are no empty wells, reducing wastage and consumable costs. With the DxN VERIS Molecular Diagnostics System, all necessary consumables and reagents are on-board, so there is no lengthy set-up and tests can be up and running in less than 10 minutes.
In addition to featuring the DxN VERIS Molecular Diagnostics System at the exhibition booth, Beckman Coulter will be presenting:
Workflow Transformed: DxN VERIS a New Fully Automated System for Molecular Diagnostics
Monday, 22 June | Room 242
EduW n. 10
Chair: Pr. Jacques lzopet
Director of Virology Department, University Hospital Purpan, Toulouse, France
Head of Core Lab in Hospital Purpan, Toulouse
Director INSERM Unit U1043
National Reference Center for HAV and HEV
Workflow Study Approach
Speaker: Andrew Williams
Nexus Global Solutions, Inc. (NEXUS), USA
An EU Laboratory Perspective: Spain
Speaker: Pr. Jordi Vila
Director of Microbiology Department
Hospital Clinic de Barcelona, Spain
An EU Laboratory Perspective: UK
Speaker: Dr. Duncan Whittaker
Department of Virology
For more information regarding the DxN VERIS Molecular Diagnostics System, visit www.beckmancoulter.com/moleculardiagnostics.
*Not for sale or distribution in the U.S.; not available in all markets.
Tags: Workflow Optimization, Cytomegalovirus, Hepatitis C, HIV, Hepatitis B
Date Published: June 16, 2015
Source article link: Beckman Coulter International S.A. » company contact details
Screw Cap Specially Optimized for Automated Handling
COPAN Defining the Future of Human Robot Collaboration in Clinical Microbiology
Sterisart® Sterility Testing – Minimizes Contamination Risk
Real-time Incubator and Colony-counter Large Capacity - NEW ScanStation 200
High-Throughput Solution for Automated DNA/RNA Extraction and PCR Setup